Finance

Lists
ANAB:NASDAQ
AnaptysBio Inc
US$ ५०.२६
-०.२२%
(-०.११) 1D
US$ ५०.२६
०.००% (०.००)
After hours
Closed: सेप्टेम्बर ३०, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANAB...
Open
US$ ५०.१३
High
US$ ५२.०२
Low
US$ ४९.३९
Mkt. cap
१.५० अरब
Avg. vol.
४.९१ लाख
Volume
१.००
52-wk high
US$ ७२.३६
52-wk low
US$ १६.६६
EPS
-US$ ०.८८
Beta
०.४०
Shares outstanding
२.९९ करोड
No. of employees
१०४
Open
US$ ५०.१३
High
US$ ५२.०२
Low
US$ ४९.३९
Mkt. cap
१.५० अरब
Avg. vol.
४.९१ लाख
Volume
१.००
52-wk high
US$ ७२.३६
52-wk low
US$ १६.६६
EPS
-US$ ०.८८
Beta
०.४०
Shares outstanding
२.९९ करोड
No. of employees
१०४
News stories
From web sources and news partners
GuruFocus
GuruFocus
·
१४ घण्टा पहिले
ANAB Maintained by JP Morgan -- Price Target Lowered to $60.00
MarketBeat
MarketBeat
·
१४ घण्टा पहिले
JPMorgan Chase & Co. Cuts AnaptysBio (NASDAQ:ANAB) Price Target to $60.00
About AnaptysBio Inc
CEO-
Employees१०४
Founded२००५
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to ANAB in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ANAB in the last 3 months.
Highest
Current US$ ५०.२६
US$ ९५.०० (+८९.०२%)
Average
US$ ८०.०० (+५९.१७%)
Lowest
US$ ६०.०० (+१९.३८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Buy
Reiterated
US$ ६०.००
+१९.४%
09/30/2026
David Risinger
Leerink Partners
Buy
Maintained
US$ ८१.००
+६१.२%
09/23/2026
Etzer Darout
Barclays
Buy
Maintained
US$ ७५.००
+४९.२%
09/22/2026
Michael Yee
UBS
Buy
Reiterated
US$ ७६.००
+५१.२%
09/22/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$ ९५.००
+८९%
09/22/2026
Joseph Thome
TD Cowen
Buy
Reiterated
-
-
08/25/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ ९३.००
+८५%
07/21/2026
David Nierengarten
Wedbush
Buy
Reiterated
US$ ७५.००
+४९.२%
03/31/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
US$ ६६.००
+३१.३%
03/30/2026
Joon Lee
Truist Financial
Hold
Maintained
US$ ५०.००
-०.५%
03/09/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
US$ ८५.००
+६९.१%
03/05/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
US$ १४०.००
+१७८.६%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२६ मार्च
२०२६ जुन
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
२.५६ करोड
-
२.७५ करोड
-
Cost of goods sold
३.४० करोड
-
-
-
Cost of revenue
३.४० करोड
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.६२ करोड
-
-
-
Operating expense
२.६२ करोड
१.५५ करोड
-
-
Total operating expenses
६.०२ करोड
१.२८ करोड
-
-
Operating income
-३.४६ करोड
१.४७ करोड
-
-
Other non operating income
-१.०० हजार
-१.०० हजार
-
-
EBT including unusual items
-५.२८ करोड
-४१.७४ लाख
-
-
EBT excluding unusual items
-५.२८ करोड
-४१.७४ लाख
-
-
Income tax expense
४०.०० हजार
-
-
-
Effective tax rate
-०.०८%
४,३४८.१३%
-
-
Other operating expenses
-
-
-
-
Net income
-५.२९ करोड
१८.३९ करोड
-
-
Net profit margin
-२०६.९३%
६६८.९५%
-
-
Earnings per share
-१.८४
-
४.९३
-
Interest and investment income
२६.५३ लाख
१४.८६ लाख
-
-
Interest expense
-२.०९ करोड
-२.०३ करोड
-
-
Net interest expenses
-१.८२ करोड
-१.८८ करोड
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.४५ करोड
१.४७ करोड
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू